M E Lopes
Overview
Explore the profile of M E Lopes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crous P, Costa M, Kandemir H, Vermaas M, Vu D, Zhao L, et al.
Persoonia
. 2024 Apr;
51:280-417.
PMID: 38665977
Novel species of fungi described in this study include those from various countries as follows: , in leaf spots of . , on scale insect (), isolated from air, on...
2.
Goncalves R, Cunha F, Sousa-Neto B, Oliveira L, Lopes M, Rezende D, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2020 Oct;
393(12):2553-2554.
PMID: 33064165
The published online version contains figure in poor quality.
3.
Goncalves R, Cunha F, Sousa-Neto B, Oliveira L, Lopes M, Rezende D, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2020 May;
393(10):1835-1848.
PMID: 32415495
Hemorrhagic cystitis (HC) is the major dose-limiting adverse effect of the clinical use ifosfamide (IFOS). The incidence of this side effect can be as high as 75%. Mesna has been...
4.
Badoual T, Lellouche N, Bourraindeloup M, Lopes M, Duval-Moulin A, Merlet P, et al.
Arch Mal Coeur Vaiss
. 2003 Jul;
96(6):637-44.
PMID: 12868345
The knowledge regarding the links between dental and cardiac affections are generally based on empirical concepts and lead to unjustified clinical practices. Infectious endocarditis (IE) is the principal cardiac diseases...
5.
Lopes M, Le Corvoisier P, Tabet J, Su J, Badoual T, CACHIN J, et al.
Presse Med
. 2003 Mar;
32(2):79-87.
PMID: 12653034
The Effects Of Spironolactone: In patients with NYHA stage III or IV heart failure, addition of spironolactone to the treatment with conversion enzyme inhibitor, diuretic and/or digitalis leads to a...
6.
Tabet J, Lopes M, Champagne S, Su J, Merlet P, Hittinger L
Arch Mal Coeur Vaiss
. 2002 May;
95(3):204-12.
PMID: 11998336
Both experimental and clinical studies have shown a role for inflammation in the pathogenesis of heart failure. This seems related to an imbalance between pro-inflammatory and anti-inflammatory cytokines. Certain categories...
7.
Hittinger L, Lopes M, Tabet J, Le Corvoisier P, Su J, Duval-Moulin A, et al.
Presse Med
. 2002 Feb;
31(1 Pt 1):33-42.
PMID: 11826585
TODAY: The management of heart failure (HF) has considerably progressed over the last two decades. Treatment today relies on prevention and treatment of congestion (limited salt intake, diuretics, converting enzyme...
8.
Le Corvoisier P, Lopes M, Duval-Moulin A, Antakly Y, Merlet P, Gueret P, et al.
Arch Mal Coeur Vaiss
. 2002 Jan;
94(11):1147-54.
PMID: 11794981
The aim of this study was to examine the nature of cardiovascular deaths occurring in a University Hospital. All the hospital files of 1999 of the Federation of Cardiology of...
9.
10.
Le Corvoisier P, Lopes M, Su J, Hittinger L
J Soc Biol
. 2001 Apr;
194(3-4):143-9.
PMID: 11324316
The benefit effects of nitric oxide (NO) donors in acute heart failure have led to the development of vasodilators as treatment of chronic heart failure. However, the mechanisms involved in...